vimarsana.com
Home
Live Updates
Galapagos Stock: Strong On Jyseleca Positive Clinical Data (
Galapagos Stock: Strong On Jyseleca Positive Clinical Data (
Galapagos Stock: Strong On Jyseleca Positive Clinical Data (GLPG)
Galapagos' flagship product, Jyselec, is used to treat rheumatoid arthritis and ulcerative colitis. Click here to read more about what makes GLPG stock a Buy.
Related Keywords
Japan ,
China ,
France ,
Romainville ,
France General ,
Galapago Jyseleca ,
European Medicines Agency ,
Contract Research Organization ,
Launches Phase ,
European Medicines ,
Galapago Phase ,
Strasbourg Based Contract Research Organization ,